Trials / Completed
CompletedNCT03351816
Impact of New Biomarkers on Maintenance of Sinus Rhythm After Cardioversion or Ablation of Atrial Fibrillation
Impact of New Biomarkers on the Maintenance of Sinus Rhythm After Cardioversion or Ablation of Atrial Fibrillation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 106 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The Biorhythm study aims to investigate the utility of new biomarkers (e.g. MR proANP, ST2) measured pre-procedure for the prediction of procedural success in patients with atrial fibrillation undergoing cardioversion or ablation.
Detailed description
This is a prospective, observational, multicentre study of patients with paroxystic or persistent atrial fibrillation scheduled to undergo cardioversion or ablation of AF in routine practice. Serum levels of MR proANP and ST2 pre-procedure will be measured to attempt to identify a threshold that carries prognostic value for procedural success (maintenance of sinus rhythm at one year).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ablation of atrial fibrillation | Pulmonary vein isolation by radiofrequency or cryoablation. |
| PROCEDURE | Cardioversion | External electric shock delivery under general anesthesia. |
Timeline
- Start date
- 2017-12-01
- Primary completion
- 2019-03-31
- Completion
- 2020-06-01
- First posted
- 2017-11-24
- Last updated
- 2020-12-23
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03351816. Inclusion in this directory is not an endorsement.